Risk perception, risk management and safety assessment: What can governments do to increase public confidence in their vaccine system?

Biologicals

Volumn 40, Issue 5, 2012, Pages 384-388

  MacDonald, Noni E ^a   Smith, Jennifer ^a   Appleton, Mary ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b IWK HEALTH CENTRE   (Canada)

Author keywords

Heuristics; Social marketing; Vaccine concerns; Vaccine risk perception; Vaccine safety

Indexed keywords

ATTITUDE TO HEALTH; CLINICAL PRACTICE; CONFERENCE PAPER; DRUG SAFETY; GOVERNMENT REGULATION; HEALTH EDUCATION; HUMAN; MEDICAL DECISION MAKING; MEDICAL INFORMATION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK MANAGEMENT; VACCINATION;

ATTITUDE TO HEALTH; COMMUNICATION; GOVERNMENT; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; MASS VACCINATION; NATIONAL HEALTH PROGRAMS; PATIENT EDUCATION AS TOPIC; PATIENT SAFETY; PERCEPTION; PUBLIC OPINION; RISK; RISK MANAGEMENT; VACCINES;

EID: 84865614039     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2011.08.001     Document Type: Conference Paper

References (32)

1. Callereus T. Perceptions of vaccine safety in a global context. Acta Paediatr 2010, 99:166-171.
2. Ogilvie G., Anderson M., Marra F., McNeil S., Pielak K., Dawar M., et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med 2010 May 4, 7(5):e1000270.
3. Leitmeyer K., Buchholz U., Kramer M., Schenkel K., Stahlhut H., Köllstadt M., et al. Influenza vaccination in German health care workers: effects and findings after two rounds of a nationwide awareness campaign. Vaccine 2006, 24:7003-7008.
4. Caban-Martinez A.J., Lee D.J., Davila E.P., LeBlanc W.G., Arheart K.L., McCollister K.E., et al. Sustained low influenza immunization rates in US healthcare workers. Prev Med 2010, 50:210-212.
5. Interim results: influenza A (H1N1) 2009 Monovalent and seasonal influenza vaccination Coverage among health-care Personnel - United States, August 2009-January 2010. MMWR Apr 2, 2010, 59(12):357-362. Centers for Disease Control and Prevention.
6. Benin A.L., Wisler-Scher D.J., Colson E., Shapiro E.D., Holmboe E.S. Qualitative analysis of mothers' decision-making about vaccines for infants: the importance of trust. Pediatrics 2006, 117(5):1532-1541.
7. Freed G.L., Clark S.J., Butchart A.T., Singer D.C., Davis M.M. Parental vaccine safety concerns in 2009. Pediatrics 2010, 125(4):654-659.
8. Zhang J., While A.E., Norman I.J. Knowledge and attitudes regarding influenza vaccination among nurses: a research review. Vaccine 2010, 28(44):7207-7214.
9. Ball L.K., Evans G., Bostrom A. Risky business: challenges in vaccine risk communication. Pediatrics 1998, 101:453-458.
10. Lau A.Y., Coiera E.W. Do people experience cognitive biases while searching for information?. Journal of the American Medical Informatics Association 2007, 14(5):599-608.
11. Galdi S., Arcuri L., Gawronski B. Automatic mental associations predict future choices of undecided decision-makers. Science 2008, 321(5892):1100-1102.
12. Scullard P., Peacock C., Davies P. Googling children's health:reliability of medical advice on the internet. Archives of Disease in Childhood 2010, 10.1136/adc.2009.168856.
13. Google Privacy Center. [accessed 2.9.2011]. http://www.google.ca/intl/en/privacy/faq.html.
14. Betsch C., Renkewitz F., Betsch T., Ulshöfer C. The influence of vaccine-critical websites on perceiving vaccination risks. J Health Psychol 2010, 15:446-455.
15. Jacobson R.M., Targonski P.V., Poland G.A. A taxonomy of reasoning flaws in the anti-vaccine movement. Vaccine 2007, 25(16):3146-3152.
16. Chen R.T., Rastogi S.C., Mullen J.R., Hayes S.W., Cochi S.L., Donlon J.A., et al. The vaccine adverse event reporting system (VAERS). Vaccine 1994, 12:542-550.
17. Black S., Rappuoli R. A crisis of public confidence in vaccines. Sci Translational Med 2010, 2(61):61. mr1.
18. British Columbia Centre for Disease Control. Immunization communication tool for immunizers. [accessed 2.9.2011]. http://www.bccdc.ca/NR/rdonlyres/DADA3304-7590-48AC-8D2C-65D54ADFC77E/0/CDC_IC_Tool.pdf.
19. MacDonald N.E., Hebert P.C. Polio outbreak in Tajikistan is cause for alarm. CMAJ 2010, 182(10):1013.
20. California Department of Public Health. Pertussis Report January 7, 2011. http://www.cdph.ca.gov/programs/immunize/Documents/PertussisReport2011-01-07.pdf.
21. Update: mumps outbreak - New York and New Jersey, June 2009-January 2010. MMWR Morbidity and Mortality Weekly Report 2010, 59(5):125-129. Centers for Disease Control and Prevention.
22. Mangold W.Glynn, Faulds David J. Social media: the new hybrid element of the promotion mix. Business Horizons 2009, 52(4):357-365.
23. Black S., Eskola J., Siegrist C., Halsey N., MacDonald N.E., Law B., et al. Importance of background rates of disease in assessment of vaccine safety during mass immunization with pandemic H1N1 influenza vaccines. Lancet 2009, 374(9707):2115-2122. 8. 10.1016/S0140-6736(09)61877.
24. MacDonald N.E., Pickering L. Canadian Paediatric Society, infectious diseases and immunization committee. Canada's eight-step vaccine safety program: vaccine literacy. Paediatr Child Health 2009, 14(9):605-608.
25. MacDonald N.E., Picard A. A plea for clear language on vaccine safety. CMAJ 2009, 180(7):697-698.
26. Smith J.C. The structure, role and procedures of the U.S. Advisory Committee on immunization practices (ACIP). Vaccine 2010, 28S:A68-A75.
27. Jacobson R.M., Targonski P.V., Poland G.A. Meta-analyses in vaccinology. Vaccine 2007, 25(16):3153-3159.
28. Jacobson R.M., Targonski P.V., Poland G.A. Why is evidence-based medicine so harsh on vaccines? An exploration of the method and its natural biases. Vaccine 2007, 20;25(16):3165-3169.
29. Taddio A., Appleton M., Bortolussi R., Chambers C., Dubey V., Halperin S., et al. Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline (summary). CMAJ 2010, 182(18):1989-1995.
30. Faunce T., Townsend R., McEwan A. The Vioxx pharmaceutical scandal: Peterson v Merke Sharpe & Dohme (Aust) Pty Ltd (2010) 184 FCR 1. Law Med 2010, 18(1):38-49.
31. World Health Organization. Mobilizing for action. Communication -for- Behavioural- Impact (COMBI) http://www.k4health.org/sites/default/files/COMBI.pdf.
32. Behl A.S. Community-level incentives to increase the use of vaccination services in developing countries: an idea whose time has come?. Vaccine 2010, 28:6123-6124.